Patient Testimonials Can't Go Beyond Efficacy Shown In Clinical Trials, FDA Says In Ad Letter For Lilly's Adcirca

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".